Nuclear Medicine And Biology

Nuclear Medicine And Biology

核医学与生物学

  • 4区 中科院分区
  • Q1 JCR分区

期刊简介

《Nuclear Medicine And Biology》是由Elsevier Inc.出版社于1993年创办的英文国际期刊(ISSN: 0969-8051,E-ISSN: 1872-9614),该期刊长期致力于核医学领域的创新研究,主要研究方向为医学-核医学。作为SCIE收录期刊(JCR分区 Q1,中科院 4区),本刊采用OA未开放获取模式(OA占比0.0953...%),以发表核医学领域等方向的原创性研究为核心(研究类文章占比100.00%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在38篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Nuclear Medicine And Biology审稿周期约为 一般,3-8周 约8周。该刊近年未被列入国际预警名单,年发文量约38篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • Multi-Language 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 38 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学
4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学
4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING SCIE Q1 36 / 204

82.6%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING SCIE Q2 53 / 204

74.26%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:6 SJR:0.658 SNIP:0.787
学科类别 分区 排名 百分位
大类:Medicine 小类:Radiology, Nuclear Medicine and Imaging Q1 71 / 333

78%

大类:Medicine 小类:Cancer Research Q2 107 / 230

53%

大类:Medicine 小类:Molecular Medicine Q2 89 / 178

50%

期刊发文

  • A radiopharmaceutical [89Zr]Zr-DFO-nimotuzumab for immunoPET with epidermal growth factor receptor expression in vivo

    Author: Yu Tang, Yingjiang Hu, Weihao Liu, Lin Chen, Yan Zhao, Huan Ma, Jijun Yang, Yuanyou Yang, Jiali Liao, Jiming Cai, Yue Chen, Ning Liu

    Journal: NUCLEAR MEDICINE AND BIOLOGY, 2019, Vol.70, 23-31, DOI:10.1016/j.nucmedbio.2019.01.007

  • In vivo imaging characterization and anticancer efficacy of a novel HER2 affibody and pemetrexed conjugate in lung cancer model

    Author: Honglei Jiao, Xinming Zhao, Jiahui Liu, Tuo Ma, Zhaoqi Zhang, Jingmian Zhang, Jianfang Wang

    Journal: NUCLEAR MEDICINE AND BIOLOGY, 2018, Vol., , DOI:10.1016/j.nucmedbio.2018.11.004

  • Radiosynthesis and biological evaluation of N-(2-[18F]fluoropropionyl)-3,4-dihydroxy-l-phenylalanine as a PET tracer for oncologic imaging

    Author: Caihua Tang, Dahong Nie, Ganghua Tang, Siyuan Gao, Shaoyu Liu, Fuhua Wen, Xiaolan Tang

    Journal: NUCLEAR MEDICINE AND BIOLOGY, 2017, Vol.50, 39-46, DOI:10.1016/j.nucmedbio.2017.04.002

  • 99mTc-3PRGD2 scintigraphy to stage liver fibrosis and evaluate reversal after fibrotic stimulus withdrawn

    Author: Xin Zhang, Qiyong Guo, Yu Shi, Weina Xu, Shupeng Yu, Zhiguang Yang, Li Cao, Changping Liu, Zhoushe Zhao, Jun Xin

    Journal: NUCLEAR MEDICINE AND BIOLOGY, 2017, Vol.49, 44-49, DOI:10.1016/j.nucmedbio.2017.02.004

  • Simple and rapid radiosynthesis of N-18F-labeled glutamic acid as a hepatocellular carcinoma PET tracer

    Author: Aixia Sun, Shaoyu Liu, Xiaolan Tang, Dahong Nie, Ganghua Tang, Zhanwen Zhang, Fuhua Wen, Xiaoyan Wang

    Journal: NUCLEAR MEDICINE AND BIOLOGY, 2017, Vol.49, 38-43, DOI:10.1016/j.nucmedbio.2017.02.003

  • Effect of methoxy group position on biological properties of 18F–labeled benzyl triphenylphosphonium cations

    Author: Shuting Chen, Zuoquan Zhao, Ying Zhang, Wei Fang, Jie Lu, Xianzhong Zhang

    Journal: NUCLEAR MEDICINE AND BIOLOGY, 2017, Vol.49, 16-23, DOI:10.1016/j.nucmedbio.2017.02.002

  • Gefitinib enhances radiotherapeutic effects of 131I–hEGF targeted to EGFR by increasing tumor uptake of hEGF in tumor xenografts

    Author: Lu Xia, He Peng, Luo Zhiqiang, Zhang Xiaoli

    Journal: NUCLEAR MEDICINE AND BIOLOGY, 2017, Vol.48, 63-68, DOI:10.1016/j.nucmedbio.2017.01.013

  • 99mTc-labeling and evaluation of a HYNIC modified small-molecular inhibitor of prostate-specific membrane antigen

    Author: Xiaoping Xu, Jianping Zhang, Silong Hu, Simin He, Xiao Bao, Guang Ma, Jianmin Luo, Jingyi Cheng, Yingjian Zhang

    Journal: NUCLEAR MEDICINE AND BIOLOGY, 2017, Vol.48, 69-75, DOI:10.1016/j.nucmedbio.2017.01.010